Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

37.40
-0.5100-1.35%
Post-market: 37.420.0196+0.05%19:59 EDT
Volume:12.66M
Turnover:475.69M
Market Cap:166.99B
PE:9.34
High:37.97
Open:37.80
Low:37.37
Close:37.91
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.87
T/O Rate:0.40%
Dividend:1.72
Dividend Rate:4.60%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.13
PE(LYR):10.33

Loading ...

Novo Nordisk Details Progress on DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Sep 21

European Equities Traded in the US as American depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Sep 21

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 7.85%

TIPRANKS
·
Sep 21

Novo Nordisk Says New Obesity Drug Outperformed Lilly's Zepbound in Phase 3 Trial

Dow Jones
·
Sep 21

Novo Nordisk A/S Stock (NVO) Moved Down by 7.86% on Sep 21: A Full Analysis

TradingKey
·
Sep 21

Novo Stock (NVO) Sinks Despite Beating Eli Lilly in New CagriSema Obesity Trial

TIPRANKS
·
Sep 21

Movement Alert|Novo-Nordisk A/S Falls 5.1% in Regular Trading, CagriSema Data Fails to Impress Market Despite Beating Tirzepatide

Market Focus
·
Sep 21

Sector Update: Healthcare

MT Newswires Live
·
Sep 21

Update: Oil Price Decline Lifts US Equity Futures Pre-Bell

MT Newswires Live
·
Sep 21

Why Novo Stock is Dropping After Drugmaker Unveils Ambitious Growth Plan

Dow Jones
·
Sep 21

【US Pre-Market】US-China Talks Boost Markets, Bitcoin Rises to $85,000, Greenland Concept Stocks Surge, Oil Falls for Fourth Day

TradingKey
·
Sep 21

Novo Nordisk's Weight-Loss, Diabetes Drug Candidate Meets Primary Goals

MT Newswires Live
·
Sep 21

Goldman Sachs Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Sep 21

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

Reuters
·
Sep 21

Why Is Novo Stock (NVO) Falling in Pre-Market Today, September 21?

TIPRANKS
·
Sep 21

Novo Nordisk Drops Over 7% Pre-Market as Wegovy Sales Miss Expectations

TradingKey
·
Sep 21

Market Chatter: Novo Nordisk Urged by Shareholders to Develop New Medicines, Pursue Acquisitions

MT Newswires Live
·
Sep 21

Novo Nordisk Aims for $23 Billion in 2035 Pipeline Sales

MT Newswires Live
·
Sep 21

Novo Nordisk Stock Tumbles as Ozempic Maker Sets Out 2030 Goals

Dow Jones
·
Sep 21

Wegovy Maker Novo Nordisk Targets Several New Blockbuster Drugs in Coming Years

Dow Jones
·
Sep 21